SMi proudly present their 2012 RNAi & Nanotechnology conference. Featuring presentations on new technologies from senior industry executives from all over the pharmaceutical sector, this event promises to be the perfect forum for networking and problem solving with key opinion leaders in the field.New for 2012: focus on the utility of nanotechnology to aid the delivery and development of novel therapeutics in the field of RNAi, miRNA and siRNA. 7 Reasons why you should attend:Understand structure-activity relationships of chitosan/siRNA nanoparticles in vitro and in vivoEvaluating targeted exosomes for targeted delivery of oligonucleotidesDiscuss antisense RNA oligonucelotide delivery by nanoconstructsExploring translational research by targeting RNA with locked nucleic acidsUpdates in RNAi and antisense technologiesLearn about novel methods for assessing oligonucelotide loading and efficacyDevelop you understanding of nanotechnology commercialization strategies